Scorpius Holdings Inc (SCPX) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Scorpius Holdings inc   (SCPX)


Scorpius Holdings Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Scorpius Holdings Inc's ROI in the third quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Scorpius Holdings Inc 's return on investment (ROI) in its third quarter of 2025

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM - -79.31 % -60.86 % -49.67 % -48.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -7 -7 -5 10 32
Return On Investment (TTM) - - - -126.28 % -88.48 %
SCPX's Overall Ranking # # # # #
Seq. Investment Change TTM - -56.37 % -35.95 % -20.23 % -7.19 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -36 -41 -34 -30

SCPX Company Profile >> Back to SCPX Roi Comparisons >> See Annual SCPX Return On Investment



Return On Investment SCPX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 



  News about Scorpius Holdings inc Return on Investment ROI

Scorpius Holdings Inc's Ambitious Partnership Amidst Financial Turmoil: A Journey Towards Redemption,

September 9, 2024



Scorpius Holdings Inc, a leading player in the healthcare sector, has been selected to join the Rapid Response Partnership Vehicle (RRPV) in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). This partnership aims to expedite the development of critical solutions for public health threats, including pandemic preparedness and emerging infectious diseases. However, despite this positive news, Scorpius Holdings Inc has recorded a significant net loss of $-28 million in the past 12 months, resulting in a negative return on investment (ROI) of -76.95%.
1. Collaborative Efforts to Address Public Health Threats:
Scorpius Holdings Inc s partnership with BARDA through the RRPV program signifies a significant step towards addressing critical public health threats. With a focus on pandemic preparedness and emerging infectious diseases, this collaboration aims to expedite the development of medical countermeasures to safeguard global public health. The company s participation in such influential initiatives highlights its commitment to protecting and enhancing public well-being.





Financial Statements
Scorpius Holdings Inc's III. Quarter Investments $ -7 Millions SCPX's Balance sheet
Scorpius Holdings Inc's III. Quarter Income $ -1 Millions Quarterly SCPX's Income Statement
SCPX's Income by Division See SCPX's Income by Division


SCPX Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 10 38 85 115 120
Y / Y Investment Growth -72.87 % -55.42 % -26.3 % -3.86 % 600.24 %
Net Income in Millions -34 -47 -44 -35 -26
Y / Y Net Income Growth - - - - -
Annual Return On Investment -334.37 % -123.78 % -51.68 % -30.74 % -22.02 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SCPX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SCPX's Competitors
Subscribers only: Roi for Scorpius Holdings Inc's Suppliers
Subscribers only: Return On Investment for SCPX's Customers

Other Ratios
SCPX's Roa SCPX's Inventory Turnover Ratio SCPX's Growth Rates SCPX's Dividend Statistics
SCPX's Profitability Ratios SCPX's Asset Turnover Ratio SCPX's Dividend Growth
SCPX's Roe SCPX's Valuation Ratios SCPX's Financial Strength Ratios SCPX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI
Carisma Therapeutics Inc   1,948.98 %
Glucotrack Inc   460.92 %
Atara Biotherapeutics Inc   404.88 %

Date modified: 2026-09-08T22:08:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.